MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Wearable Sensors for Quantitative Motor Assessments in Multiple System Atrophy

D. Claassen, J. Iregui, A. Wynn, C. Davis, C. Wong, D. Stamler (Nashville, USA)

Meeting: 2022 International Congress

Abstract Number: 1081

Keywords: Multiple system atrophy(MSA): Clinical features

Category: Parkinsonism, Atypical: MSA

Objective: To determine the utility of quantitative wearable sensors in Multiple system atrophy (MSA).

Background: Symptoms of MSA include parkinsonism, ataxia, and/or failure of the autonomic nervous system. Wearable sensors to assess gait and activity parameters in MSA have potential to characterize motor impairment in an outpatient setting and to serve as clinical trial outcomes.

Method: Participants enrolled in biomarkers of progression in MSA (bioMUSE) were diagnosed with early MSA (<3 years of motor symptoms) by clinical assessment. All completed a neurologic exam, neuroimaging and biofluid assessments. The motor exam of the Unified MSA Rating Scale (UMSARS II) , Parkinson Plus Scale (PPSm), and Tandem Walk (TW), were completed every 3 months. PAMSys actigraphy pendant sensors were worn continuously for up to 12-months, allowing assessment of gait parameters (step count, bouts of walking, steps per bout, cadence, cadence variability), postures (minutes of sitting, lying, standing, walking, sedentary [sitting + lying]) and postural transitions (sit to stand). Clinical assessments were obtained at baseline (BL) and months 3, 6, 9 and 12.   At each time point, sensor parameters were obtained by averaging data over 14-day epochs.   Pearson correlation coefficients between each clinical variable and each sensor variable were estimated at each time point.  The two-sided p-value from the test of the null hypothesis that the true correlation equals zero was computed.

Results: 12 participants (6 Female, mean age 64.2) with an average motor symptom duration of 2 years were followed for ≥ 6 months (n=9), and 12 months (n=5). Significant (P<0.05) correlations were observed between step count, bouts of walking, minutes walking and sit to stand transitions for UMSARS II, PPSm and TW. Significant correlations were most frequently observed at BL and months 3, 6 and 9. The strongest correlations (r>0.8) were observed at month 6 and 9.  The PPSm had more frequent and stronger correlation with sensor parameters than UMSARS II.

Conclusion: In early MSA, continuous activity monitoring is feasible and demonstrates significant correlation with motor exam. The PPSm appeared to have stronger correlation with sensor variables than UMSARS II. Continuous motor assessments via a wearable pendant may be a suitable endpoint for clinical trials in MSA.

To cite this abstract in AMA style:

D. Claassen, J. Iregui, A. Wynn, C. Davis, C. Wong, D. Stamler. Wearable Sensors for Quantitative Motor Assessments in Multiple System Atrophy [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/wearable-sensors-for-quantitative-motor-assessments-in-multiple-system-atrophy/. Accessed July 12, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/wearable-sensors-for-quantitative-motor-assessments-in-multiple-system-atrophy/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Welcome to the MDS Abstracts Site
  • Advanced Search
  • DaTscan in clinical evaluation of Multiple System Atrophy
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley